David Roblin (Relation)
Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D
Having been involved in a number of attrition task force efforts during his tenure as European R&D chief at Pfizer, David Roblin tells me there’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
